We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Paladin Labs

News List

Radius Health Announces Commercial Agreement with Paladin Labs for Abaloparatide in Canada americanpharmaceuticalreview
January 13, 2021
Radius Health has entered into definitive agreements with Endo Ventures Limited, a subsidiary of Endo International, to register, commercialize, and distribute abaloparatide on an exclusive basis in Canada.
Paladin Labs Inc. Announces Approval of Envarsus PA (tacrolimus prolonged-release tablets) in Canada firstwordpharma
February 23, 2019
Paladin Labs Inc. and Endo Ventures Limited, subsidiaries of Endo International plc (NASDAQ: ENDP), today announced Health Canada's approval of Envarsus PA™(tacrolimus prolonged-release tablets) for the prophylaxis of organ rejection in kidney or liver t